BACKGROUND: This study describes the characteristics of a large sample of patients hospitalised for the first time for a chronic obstructive pulmonary disease (COPD) exacerbation. METHODS: All subjects first admitted for a COPD exacerbation to nine teaching Spanish hospitals during January 2004-March 2006, were eligible. COPD diagnosis was confirmed by spirometry under stability. At admission, sociodemographic data, lifestyle, previous treatment and diagnosis of respiratory disease, lung function and Charlson index of co-morbidity were collected. A comprehensive assessment, including dyspnea, lung function, six-minute walking test, and St. George's Respiratory Questionnaire (SGRQ), was completed 3 months after admission, during a clinically stable disease period. RESULTS: Three-hundred and forty-two patients (57% of the eligible) participated in the study: 93% males, mean (SD) age 68 (9) years, 42% current smokers, 50% two or more co-morbidities, 54% mild-to-moderate dyspnea, post-bronchodilator FEV(1) 52 (16)% of predicted (54% mild-to-moderate COPD in ATS/ERS stages), 6-min walking distance 440 m, total SGRQ score 37 (18), and 36% not report respiratory disease. The absence of a previous COPD diagnosis, positive bronchodilator test, female gender, older age, higher DLco and higher BMI were independently associated with less severe COPD. CONCLUSIONS: We show that the patients admitted after presenting with their first COPD exacerbation have a wide range of severity, with a large proportion of patients in the less advanced COPD stages.
BACKGROUND: This study describes the characteristics of a large sample of patients hospitalised for the first time for a chronic obstructive pulmonary disease (COPD) exacerbation. METHODS: All subjects first admitted for a COPD exacerbation to nine teaching Spanish hospitals during January 2004-March 2006, were eligible. COPD diagnosis was confirmed by spirometry under stability. At admission, sociodemographic data, lifestyle, previous treatment and diagnosis of respiratory disease, lung function and Charlson index of co-morbidity were collected. A comprehensive assessment, including dyspnea, lung function, six-minute walking test, and St. George's Respiratory Questionnaire (SGRQ), was completed 3 months after admission, during a clinically stable disease period. RESULTS: Three-hundred and forty-two patients (57% of the eligible) participated in the study: 93% males, mean (SD) age 68 (9) years, 42% current smokers, 50% two or more co-morbidities, 54% mild-to-moderate dyspnea, post-bronchodilator FEV(1) 52 (16)% of predicted (54% mild-to-moderate COPD in ATS/ERS stages), 6-min walking distance 440 m, total SGRQ score 37 (18), and 36% not report respiratory disease. The absence of a previous COPD diagnosis, positive bronchodilator test, female gender, older age, higher DLco and higher BMI were independently associated with less severe COPD. CONCLUSIONS: We show that the patients admitted after presenting with their first COPD exacerbation have a wide range of severity, with a large proportion of patients in the less advanced COPD stages.
Authors: Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich Journal: Thorax Date: 2017-06-21 Impact factor: 9.139
Authors: Peter Ascanius Jacobsen; Kristian Kragholm; Christian Torp-Pedersen; Ulla Møller Weinreich Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-10-11
Authors: Eva Balcells; Joaquim Gea; Jaume Ferrer; Ignasi Serra; Mauricio Orozco-Levi; Jordi de Batlle; Esther Rodriguez; Marta Benet; David Donaire-González; Josep M Antó; Judith Garcia-Aymerich Journal: Health Qual Life Outcomes Date: 2010-09-27 Impact factor: 3.186
Authors: Eva Balcells; Elena Gimeno-Santos; Jordi de Batlle; Maria Antonia Ramon; Esther Rodríguez; Marta Benet; Eva Farrero; Antoni Ferrer; Stefano Guerra; Jaume Ferrer; Jaume Sauleda; Joan A Barberà; Àlvar Agustí; Robert Rodriguez-Roisin; Joaquim Gea; Josep M Antó; Judith Garcia-Aymerich Journal: BMC Pulm Med Date: 2015-01-17 Impact factor: 3.317
Authors: Esther Rodríguez; Jaume Ferrer; Jan-Paul Zock; Ignasi Serra; Josep M Antó; Jordi de Batlle; Hans Kromhout; Roel Vermeulen; David Donaire-González; Marta Benet; Eva Balcells; Eduard Monsó; Angel Gayete; Judith Garcia-Aymerich Journal: PLoS One Date: 2014-02-06 Impact factor: 3.240